University of Colorado Boulder 1002172800

loxP-CFD LHA 3; CD79a LHA 5; pAAV-CFD LHA 5; ZP3 int 5; SV40 int 3; loxP-CFD RHA 5; CFD flox 3; bGH pA 5; CFD LRPCR 3...

On August 6, 2025, the University of Colorado Boulder, a public college or university in Colorado, issued a single-transaction purchase order to Integrated DNA Technologies Inc for a total obligated amount of $274.41. The order includes numerous genetic research reagents and oligos such as loxP-CFD LHA 3, CD79a LHA 5, pAAV-CFD LHA 5, and others, primarily for research purposes. The purchase is part of a contract, with no indication of multiple years or blanket arrangements. The award involves detailed genetic products with specified parts and quantities, supplied by the vendor Integrated DNA Technologies Inc. The buyer contact details are not specified. The award is categorized as higher education (public college or university). The award was made in Boulder, Colorado, United States, and the jurisdiction code is 'US' with the state code 'CO'. Likely competitors for similar awards in this sector include biotech and research reagent companies such as Thermo Fisher Scientific, Bio-Rad, and OriGene.

Description

loxP-CFD LHA 3; CD79a LHA 5; pAAV-CFD LHA 5; ZP3 int 5; SV40 int 3; loxP-CFD RHA 5; CFD flox 3; bGH pA 5; CFD LRPCR 3; Nr0b1 int 5; pAAV-CFD RHA 3; RHA 5; CD79a e4+5 5; CFD flox 5; CD79a LHA 3; bGH pA-CD79 e4+5 3; RNase12 int 5; CD79a ind LRPCR 3; bGH pA 3; RHA 3; CD79a ind LRPCR 5